AU2016901555A0 - CD43 binding proteins and uses thereof - Google Patents

CD43 binding proteins and uses thereof

Info

Publication number
AU2016901555A0
AU2016901555A0 AU2016901555A AU2016901555A AU2016901555A0 AU 2016901555 A0 AU2016901555 A0 AU 2016901555A0 AU 2016901555 A AU2016901555 A AU 2016901555A AU 2016901555 A AU2016901555 A AU 2016901555A AU 2016901555 A0 AU2016901555 A0 AU 2016901555A0
Authority
AU
Australia
Prior art keywords
binding proteins
proteins
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016901555A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Teva Pharmaceuticals Australia Pty Ltd
Filing date
Publication date
Application filed by Teva Pharmaceuticals Australia Pty Ltd filed Critical Teva Pharmaceuticals Australia Pty Ltd
Publication of AU2016901555A0 publication Critical patent/AU2016901555A0/en
Priority to SG11201803008RA priority Critical patent/SG11201803008RA/en
Priority to CA3001676A priority patent/CA3001676C/en
Priority to NZ74157316A priority patent/NZ741573A/en
Priority to JP2018538512A priority patent/JP6758388B2/en
Priority to MX2018004474A priority patent/MX2018004474A/en
Priority to CN201680072698.5A priority patent/CN108472364B/en
Priority to RU2018115692A priority patent/RU2694903C1/en
Priority to KR1020187011372A priority patent/KR101981943B1/en
Priority to BR122021000898A priority patent/BR122021000898A8/en
Priority to BR112018007334A priority patent/BR112018007334A8/en
Priority to US15/767,179 priority patent/US10676531B2/en
Priority to AU2016339513A priority patent/AU2016339513B2/en
Priority to PCT/KR2016/011428 priority patent/WO2017065493A1/en
Priority to EP16855710.6A priority patent/EP3363461A4/en
Priority to IL258642A priority patent/IL258642B/en
Priority to ZA2018/02618A priority patent/ZA201802618B/en
Priority to JP2020081490A priority patent/JP2020125352A/en
Priority to US16/871,280 priority patent/US11542339B2/en
Abandoned legal-status Critical Current

Links

AU2016901555A 2015-10-12 2016-04-28 CD43 binding proteins and uses thereof Abandoned AU2016901555A0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
EP16855710.6A EP3363461A4 (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment
BR122021000898A BR122021000898A8 (en) 2015-10-12 2016-10-12 ANTI-CD43 ANTIBODY AND ITS USE FOR CANCER TREATMENT
BR112018007334A BR112018007334A8 (en) 2015-10-12 2016-10-12 ANTI-CD43 ANTIBODY AND ITS USE FOR CANCER TREATMENT
NZ74157316A NZ741573A (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment
JP2018538512A JP6758388B2 (en) 2015-10-12 2016-10-12 Anti-CD43 antibody and its cancer therapeutic use
MX2018004474A MX2018004474A (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment.
CN201680072698.5A CN108472364B (en) 2015-10-12 2016-10-12 anti-CD 43 antibodies and their use in cancer therapy
RU2018115692A RU2694903C1 (en) 2015-10-12 2016-10-12 Cd43 antibodies and use thereof for treating cancer
KR1020187011372A KR101981943B1 (en) 2015-10-12 2016-10-12 Anti-CD43 antibodies and their use in the treatment of cancer
SG11201803008RA SG11201803008RA (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment
CA3001676A CA3001676C (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment
US15/767,179 US10676531B2 (en) 2015-10-12 2016-10-12 Anti-CD43 antibody and use thereof for cancer treatment
AU2016339513A AU2016339513B2 (en) 2015-10-12 2016-10-12 Anti-CD43 antibody and use thereof for cancer treatment
PCT/KR2016/011428 WO2017065493A1 (en) 2015-10-12 2016-10-12 Anti-cd43 antibody and use thereof for cancer treatment
IL258642A IL258642B (en) 2015-10-12 2018-04-11 Anti-cd43 antibody and use thereof for cancer treatment
ZA2018/02618A ZA201802618B (en) 2015-10-12 2018-04-19 Anti-cd43 antibody and use thereof for cancer treatment
JP2020081490A JP2020125352A (en) 2015-10-12 2020-05-01 Anti-cd43 antibody and use thereof for cancer treatment
US16/871,280 US11542339B2 (en) 2015-10-12 2020-05-11 Anti-CD43 antibody and use thereof for cancer treatment

Publications (1)

Publication Number Publication Date
AU2016901555A0 true AU2016901555A0 (en) 2016-05-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP3612218A4 (en) Trem2 antigen binding proteins and uses thereof
EP3452089A4 (en) Bispecific binding proteins and uses thereof
EP3652212A4 (en) Antibodies binding lag-3 and uses thereof
EP3383916A4 (en) Anti-cd73 antibodies and uses thereof
EP3655432A4 (en) Binding proteins 1
EP3544628A4 (en) 4-1bb binding proteins and uses thereof
EP3504243A4 (en) Anti-tim-3 antibodies and use thereof
EP3625263A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3596119A4 (en) Anti-phf-tau antibodies and uses thereof
EP3389702A4 (en) Anti-lag-3 antibodies and uses thereof
EP3665303A4 (en) Clec9a binding agents and use thereof
EP3436068A4 (en) Binding proteins and methods of use thereof
EP3324996A4 (en) Gdf11 binding proteins and uses thereof
EP3426288A4 (en) Anti-pacap antibodies and uses thereof
EP3515491A4 (en) Cd123 binding proteins and related compositions and methods
EP3613772A4 (en) Binding molecule specific for lrig-1 protein and use thereof
EP3515948A4 (en) Coagulation factor binding proteins and uses thereof
EP3444270A4 (en) Novel natural protein and application thereof
EP3451837A4 (en) Insecticidal proteins and methods for their use
EP3290441A4 (en) RGMa BINDING PROTEIN AND USE THEREOF
EP3645563A4 (en) Anti-fam19a5 antibodies and uses thereof
EP3380514A4 (en) Cd131 binding proteins and uses thereof
EP3445394A4 (en) Alk7 binding proteins and uses thereof
EP3722305A4 (en) Hm-3 fusion protein and use thereof
EP3541848A4 (en) Methods for protein ligation and uses thereof